In this study, the selection of MATN3 as a target was guided by our RNA sequencing data, which identified MATN3 as one of the most significantly downregulated genes after α-Pinene treatment in hepatocellular carcinoma cell line. Here, MATN3 is linked to hepatocellular carcinoma.